Donor cells take on Drug-Resistant viruses in new trial
NCT ID NCT07670468
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tests a treatment called LB-DTK-MV, which uses immune cells from a healthy donor to fight three viruses (CMV, BKV, and EBV) that have become resistant to standard antiviral drugs. The study includes 27 adults who have had a stem cell transplant or certain cancer therapies. Participants receive two infusions of these donor cells, and researchers will monitor safety, side effects, and whether the viral levels drop.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LB-DTK-MV (donor immune cells targeting multiple viruses)
What this could lead to
If successful, this could offer a new treatment option for patients with dangerous viral infections that do not respond to standard antiviral drugs after cancer therapy or stem cell transplant.
What could go wrong
This is an early-phase trial with only 27 participants, so results may not apply to everyone. There is a risk of side effects, and the treatment may not effectively clear the viruses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CMV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Catholic University of Korea Seoul St.Mary's Hospital
RECRUITINGSeoul, 06591, South Korea
Contact